Telemedicine Growth in the MENA Region: A Digital Healthcare Revolution

By Melike Belenli Gümüş

October 23, 2024

A recent article provides a comprehensive overview of the growing adoption of telemedicine and its significant impact in the Middle East and North Africa (MENA) region. Telemedicine has become increasingly essential as it transforms healthcare delivery, particularly in remote and underserved areas. Here are the key points:

Telemedicine Growth in the MENA

The telehealth market in the MENA region is expected to grow significantly, with a projected Compound Annual Growth Rate (CAGR) of 31.57% from 2024 to 2030. This growth is driven by improved internet connectivity, the proliferation of smartphones, and government initiatives to promote telemedicine.

Impact of the COVID-19 Pandemic

The COVID-19 pandemic acted as a catalyst for the adoption of telemedicine. Prior to the pandemic, telehealth utilisation was relatively low, but by April 2020, its use surged to 78 times higher than pre-pandemic levels. This rapid increase highlighted the necessity of virtual care solutions, especially in rural areas with limited healthcare options.

Country-Specific Initiatives

Countries such as Saudi Arabia, the United Arab Emirates (UAE), and Egypt are at the forefront of this digital healthcare revolution. In the UAE, the telemedicine sector is thriving, driven by a tech-savvy population and government commitment to healthcare innovation. Kuwait has launched initiatives like the ‘Sehaty Online’ platform and a telemedical electronic portal as part of the “New Kuwait” national development plan for 2035.

Benefits of Telemedicine

Telemedicine offers numerous benefits, including convenience, as patients can access medical care from their homes. It is also cost-effective, reducing the need for physical visits to healthcare facilities. Moreover, telemedicine improves access to healthcare, particularly for individuals in rural and underserved areas where traditional healthcare facilities are limited, thereby enhancing overall healthcare accessibility.

Challenges

Despite the promising growth of telemedicine, several challenges persist. Protecting patient data remains a significant issue due to cybersecurity concerns. Regulatory barriers also pose a problem, as different regulatory requirements across various emirates and countries can hinder the expansion of telehealth services. There is a need for better integration of telehealth services into the existing healthcare infrastructure. Moreover, the growing use of telemedicine necessitates training healthcare professionals in these technologies to ensure effective implementation and use.

Future Directions

The future of telemedicine in the MENA region looks promising with continued investment in digital health technologies and growing acceptance among patients and providers. Governments and healthcare organisations are working to overcome existing challenges, and telemedicine is revolutionising healthcare delivery, making it more accessible, efficient, and patient-centered.

Technological and Infrastructure Developments

The use of general videoconferencing and teleconferencing apps like Skype and Zoom has become common for remote interactions between patients and healthcare providers. Developers are creating advanced telehealth platforms and mobile applications to provide comprehensive services, including online consultations, lab result checks, and appointment scheduling.

In summary, the article discusses the rapid growth of telemedicine in the MENA region, propelled by technological advancements, government support, and the pressing need for more accessible healthcare. While challenges remain, the overall outlook for telemedicine is positive, with it set to play a crucial role in the future of healthcare in the region.

Reference url

Recent Posts

FDA Cancer Trial Guidelines: Prioritizing Overall Survival for Patient-Centered Approvals

By João L. Carapinha

October 23, 2025

The FDA cancer trial guidelines from August 2025 emphasize overall survival (OS) as the key endpoint for oncology drug approvals. If you're wondering how these FDA cancer trial guidelines impact patient outcomes in treatment trials, they shift focus from surrogate measures like progression-free s...
Social Media Policy Action: Protecting Youth from Cognitive Risks

By João L. Carapinha

October 16, 2025

A recent editorial published in JAMA emphasizes the urgent need for social media policy action due to the developmental impacts of social media on youth. The article discusses a pivotal study by Nagata et al., which examined a large cohort of adolescents. This study revealed that increas...
Datroway TNBC Therapy: Transforming First-Line Treatment for Metastatic Triple-Negative Breast Ca...

By João L. Carapinha

October 13, 2025

Datroway TNBC therapy (datopotamab deruxtecan) has demonstrated statistically significant and clinically meaningful improvements in overall survival (OS) and progression-free survival (PFS) as a first-line treatment compared to chemotherapy in patients with metastatic triple-negative breast cance...